IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,939,000 | -21.3% | 3,292,962 | +34.4% | 0.00% | 0.0% |
| Q3 2016 | $6,274,000 | +75.8% | 2,450,736 | +5.1% | 0.00% | 0.0% |
| Q2 2016 | $3,569,000 | -19.4% | 2,332,615 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $4,426,000 | -37.9% | 2,235,490 | -3.1% | 0.00% | -50.0% |
| Q4 2015 | $7,130,000 | -5.3% | 2,307,440 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $7,526,000 | -9.8% | 2,246,640 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $8,345,000 | -7.4% | 2,249,292 | -7.4% | 0.00% | 0.0% |
| Q1 2015 | $9,010,000 | +21.0% | 2,428,564 | +43.8% | 0.00% | 0.0% |
| Q4 2014 | $7,449,000 | +128.7% | 1,689,211 | +18.8% | 0.00% | +100.0% |
| Q3 2014 | $3,257,000 | -24.3% | 1,422,301 | -4.1% | 0.00% | 0.0% |
| Q2 2014 | $4,301,000 | – | 1,483,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,094,745 | $9,563,000 | 0.59% |
| WALL STREET ASSOCIATES | 400,000 | $1,236,000 | 0.35% |
| Palo Alto Investors LP | 1,257,748 | $3,886,000 | 0.22% |
| Baker Brothers Advisors | 6,983,107 | $21,578,000 | 0.18% |
| NATIXIS | 3,148,916 | $9,730,000 | 0.16% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,149,000 | 0.12% |
| MYCIO WEALTH PARTNERS, LLC | 200,000 | $618,000 | 0.11% |
| HOLLENCREST CAPITAL MANAGEMENT | 177,570 | $549,000 | 0.10% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 701,815 | $2,169,000 | 0.07% |
| CARL DOMINO INC | 29,137 | $90,000 | 0.07% |